PhRMA DTC guidelines
This article was originally published in The Tan Sheet
Executive Summary
A list of 15 voluntary "Guiding Principles" on direct-to-consumer advertising emphasize consumer education and "exceed current FDA regulations in many ways," the Pharmaceutical Research & Manufacturers of America announces Aug. 2. PhRMA collaborated on the new guidelines for industry self-regulation with 23 pharmaceutical firms. DTC print and TV ads should "include information about the availability of other options such as diet and lifestyle," according to one of the new guidelines. PhRMA will establish an "Office of Accountability" to receive comments from consumer and healthcare professionals about DTC ads. The comments will periodically be made public and reports will be sent to FDA. PhRMA also compels companies to submit DTC television ads to FDA prior to broadcasting...
You may also be interested in...
PhRMA Guidelines May Redraw Line Between DTC, OTC Advertising
Pfizer direct-to-consumer prescription drug ads will "clearly indicate... that the medicine is a prescription medicine," the firm said in an Aug. 11 announcement of planned DTC changes
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.